Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: Effect on remission duration and survival: Cancer and leukemia group B study 8583
Howard Ozer, Stephen L. George, Charles A. Schiffer, Kathleen Rao, P. Nagesh Rao, Doris H. Wurster-Hill, Diane D. Arthur, Bayard Powell, Arlan Gottlieb, Bruce A. Peterson, Kanti Rai, Joseph R. Testa, Michelle Lebeau, Ramana Tantravahi, Clara D. Bloomfield
Research output: Contribution to journal › Article › peer-review
176Scopus
citations
Fingerprint
Dive into the research topics of 'Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: Effect on remission duration and survival: Cancer and leukemia group B study 8583'. Together they form a unique fingerprint.